COMMUNIQUÉS West-GlobeNewswire

EssilorLuxottica : Nombre total de droits de vote et d'actions composant le capital social au 31 mars 2019
02/04/2019
Nombre total de droits de vote et d’actions composant le capital social au 31 mars 2019 (Conformément à l’article L.233-8 II du Code de Commerce et aux articles 221-1 et 223-16 du Règlement Général de l’AMF) Charenton- [...]
Monthly information related to total number of voting rights and shares composing the share capital – March 31, 2019
02/04/2019
LYON, France, April 02, 2019 (GLOBE NEWSWIRE) -- Article 223-16 of general regulation of French Autorité des Marchés Financiers Lyon - France Listing markets: Euronext Paris from Euronext (Market segment C - ISIN Code: [...]
Information mensuelle relative au nombre total de droits de vote et d’actions composant le capital social - 31 Mars 2019
02/04/2019
LYON, France, 02 avr. 2019 (GLOBE NEWSWIRE) -- Article 223-16 du Règlement Général de l’Autorité des Marchés Financiers Lyon - France Places de cotation : Euronext Paris de Euronext (Compartiment C - Code ISIN : [...]
OSE Immunotherapeutics Presents New Clinical and Preclinical Data on its Immuno-Oncology Portfolio at AACR 2019
02/04/2019
Oral presentation highlights investigator case reports showing early signs of activity of Tedopi® in patients with non-small cell lung cancer in third-line treatment after checkpoint inhibitor failure Poster [...]
« L’autisme doit devenir une priorité nationale »
02/04/2019
MONTRÉAL, 02 avr. 2019 (GLOBE NEWSWIRE) -- Le taux de prévalence de l’autisme devrait en faire une priorité nationale. En 2018, le taux de prévalence de l’autisme au Canada était de 1 sur 66 et celui du Québec de 1 sur [...]
Chr. Hansen and Lonza establish a 50/50 joint venture to pioneer the emerging market for live biotherapeutic products
02/04/2019
Company Announcement No. 4/2019 Announcement attached below For further information, please contact: Head of Investor Relations Martin Riise Tel.: +45 5339 2250 Investor Relations Officer Annika Stern Tel.: +45 2399 [...]
Amfora Licenses Gene Editing Technology
02/04/2019
SAN FRANCISCO, April 02, 2019 (GLOBE NEWSWIRE) -- Today Amfora, a biotechnology company, announced it has reached a non-exclusive research and commercial license agreement with Corteva Agriscience™, the Agriculture [...]
Dr. Ellen Turner Expands Wellness Testing Opportunities in Dallas
02/04/2019
Starting in 2019, the Texas-based physician began offering tests for hormone imbalances, heavy metals, and more DALLAS, April 02, 2019 (GLOBE NEWSWIRE) -- As a Dallas-based dermatologist , Dr. Ellen Turner has long [...]
University at Buffalo Selected as First U.S. Site for LaparoGuard Augmented Surgical System
02/04/2019
Buffalo, NY, April 02, 2019 (GLOBE NEWSWIRE) -- Surgeons are pioneering LaparoGuard, a suite of new technologies for patients, at the Jacobs School of Medicine and Biomedical Sciences at the University at Buffalo (UB). [...]
Massive Bio to Present SYNERGY-AI Trial-in-Progress Poster Presentation at Upcoming AACR 2019 using its AI Clinical Trial Matching Technology, and Announces Strategic Partnership in Precision Oncology with US-Based Admera Health
02/04/2019
NEW YORK, April 02, 2019 (GLOBE NEWSWIRE) -- Massive Bio, Inc., a leader in providing simplified and affordable access to clinical trials and precision oncology to cancer patients treated at community-based oncology [...]
Zynerba Pharmaceuticals to Present at the 2019 H.C. Wainwright Global Life Sciences Conference
02/04/2019
DEVON, Pa., April 02, 2019 (GLOBE NEWSWIRE) -- Zynerba Pharmaceuticals, Inc. (NASDAQ:ZYNE), the leader in innovative pharmaceutically-produced transdermal cannabinoid therapies for rare and near-rare neuropsychiatric [...]
Wildflower Brands and HelloMD to Expand Business Together
02/04/2019
VANCOUVER, British Columbia, April 02, 2019 (GLOBE NEWSWIRE) -- via NetworkWire: Wildflower Brands Inc. (CSE: SUN , OTC: WLDFF ) (the “Company”) is pleased to have entered into a delivery fulfillment agreement with [...]
Visual Snow Initiative to present a Váró-abstract brain sculpture to MIT Neuroscientist Ed Boyden for his support to advance a ‘Visual Snow Syndrome’ cure
02/04/2019
Attn.: Boston Assignment/Photo Editors, Art Editors, Healthcare Editors, Tech Editors Media Advisory: April 3 - Photo & Interview Opportunity Who: Dr. Ed Boyden , Assoc. Professor, Biological Engineering and Brain [...]
Aptevo Therapeutics Presents New Preclinical Data for APVO436 and ALG.APV-527 at the American Association for Cancer Research 2019 Annual Meeting
02/04/2019
APVO436 Preclinical Data Continue to Show Promising Results Supporting Clinical Development for the Treatment of Acute Myeloid Leukemia (AML) and High-Grade Myelodysplastic Syndrome (MDS) and Differentiation from a [...]
Nexstim Plc: Nexstim Plc has prepared a supplement to the prospectus
02/04/2019
Company announcement, Helsinki, 2 April 2019, at 4.00 PM (EET) Nexstim Plc: Nexstim Plc has prepared a supplement to the prospectus Nexstim Plc (NXTMH:HEX, NXTMS:STO) ("Nexstim" or "Company"), the targeted [...]
Imprivata and Verato Partner to Offer an Integrated Architecture for Patient Identity
02/04/2019
Joint solution combines biometric and referential patient matching into single architecture to address the full lifecycle of patient identity LEXINGTON, Mass., April 02, 2019 (GLOBE NEWSWIRE) -- — Imprivata® , the [...]
INmune Bio to Ring the NASDAQ Closing Bell on Tuesday, April 9, 2019
02/04/2019
LA JOLLA, Calif., April 02, 2019 (GLOBE NEWSWIRE) -- INmune Bio, Inc. (NASDAQ: INMB ) (the “Company”), an immunology company focused on developing treatments that harness the patient’s innate immune system to fight [...]
Global Kinetics Corporation Appoints Greg Barrett As Independent Director to its Board of Directors
02/04/2019
PORTSMOUTH, N.H. and MELBOURNE, Australia, April 02, 2019 (GLOBE NEWSWIRE) -- Global Kinetics Pty Ltd., a medical device company focused on the development and commercialization of the first FDA-cleared and CE-marked [...]
Genmab to Present at the H.C. Wainwright & Co. Global Life Sciences Conference
02/04/2019
Media Release Copenhagen, Denmark, April 2, 2019 Genmab A/S (Nasdaq Copenhagen: GEN) announced today that its CEO, Jan van de Winkel, Ph.D., will present a company update at the H.C. Wainwright & Co. Global Life [...]

Pages